{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T10:42:54Z","timestamp":1786185774296,"version":"build-2736575974"},"reference-count":59,"publisher":"Academy of Managed Care Pharmacy","issue":"9-b Suppl","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMCP"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.18553\/jmcp.2026.32.9-b.s2","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T10:02:41Z","timestamp":1786183361000},"page":"S3-S16","source":"Crossref","is-referenced-by-count":0,"title":["Natural language processing to develop a standardized lexicon for precision medicine in oncology"],"prefix":"10.18553","volume":"32","author":[{"given":"Tianyi","family":"Wang","sequence":"first","affiliation":[{"name":"Omnicom Health Market Access, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Tsai","sequence":"additional","affiliation":[{"name":"Omnicom Health Market Access, Millington, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven S.","family":"Kheloussi","sequence":"additional","affiliation":[{"name":"Kheloussi Consulting, LLC, Wilkes-Barre, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"McCormick","sequence":"additional","affiliation":[{"name":"AMCP, Grapevine, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamala A.","family":"Pawloski","sequence":"additional","affiliation":[{"name":"AMCP Research Institute, Alexandria, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7818","reference":[{"key":"r1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2024.101329"},{"key":"r2","doi-asserted-by":"publisher","DOI":"10.1200\/OP.23.00601"},{"key":"r3","unstructured":"Blue Cross Blue Shield of Michigan. Medical policy: molecular and genomic diagnostic testing for cancer susceptibility and precision medicine. Updated February 1, 2024. Accessed May 23, 2026. https:\/\/www.bcbsm.com\/amslibs\/content\/dam\/public\/mpr\/mprsearch\/pdf\/2055797.pdf"},{"key":"r4","unstructured":"EmblemHealth. Gene expression profiling medical policy. Updated January 1, 2025. Accessed May 23, 2026. https:\/\/www.emblemhealth.com\/content\/dam\/emblemhealth\/pdfs\/provider\/medical_policies\/g\/gene-expression-profiling-medical-policy-emblemhealth.pdf"},{"key":"r5","unstructured":"Excellus BlueCross BlueShield. Molecular testing of tumor tissue to identify targeted therapies for cancers. Medical policy. Updated March 15, 2024. Accessed May 23, 2026. https:\/\/www.excellusbcbs.com\/documents\/d\/global\/exc-prv-molecular-testing-of-tumor-tissue-to-identify-targeted-therapies-for-cancers"},{"key":"r6","unstructured":"Blue Shield of California. Medical policy: biomarker testing. Updated 2024. Accessed May 23, 2026. https:\/\/beonbrand.getbynder.com\/m\/958345b7a2e491ff\/"},{"key":"r7","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocaf176"},{"key":"r8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2024.104596"},{"key":"r9","doi-asserted-by":"publisher","DOI":"10.1177\/00469580241290095"},{"key":"r10","doi-asserted-by":"publisher","DOI":"10.3389\/fsoc.2023.1112159"},{"key":"r11","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_389516"},{"key":"r12","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2025.15121"},{"key":"r13","doi-asserted-by":"publisher","DOI":"10.46747\/cfp.6807515"},{"key":"r14","unstructured":"National Cancer Institute. Targeted cancer therapies. Updated February 27, 2023. Accessed May 23, 2026. https:\/\/www.cancer.gov\/about-cancer\/treatment\/types\/targeted-therapies"},{"key":"r15","doi-asserted-by":"publisher","DOI":"10.21037\/atm-25-34"},{"key":"r16","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0768-9"},{"key":"r17","doi-asserted-by":"publisher","DOI":"10.4331\/wjbc.v6.i3.231"},{"key":"r18","unstructured":"MedlinePlus Genetics. What is a gene? National Library of Medicine. Accessed May 23, 2026. https:\/\/medlineplus.gov\/genetics\/understanding\/basics\/gene\/"},{"key":"r19","unstructured":"National Cancer Institute. Definition of gene. NCI Dictionary of Genetics Terms. Accessed May 23, 2026. https:\/\/www.cancer.gov\/publications\/dictionaries\/genetics-dictionary\/def\/gene"},{"key":"r20","doi-asserted-by":"publisher","DOI":"10.1586\/era.10.226"},{"key":"r21","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2016-0046"},{"key":"r22","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30"},{"key":"r23","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13040638"},{"key":"r24","doi-asserted-by":"publisher","DOI":"10.1177\/1535370217750088"},{"key":"r25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2025.100831"},{"key":"r26","unstructured":"FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and Other Tools) Resource. Food and Drug Administration; 2016. Updated January 28, 2021. Accessed May 25, 2026. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK326791\/"},{"key":"r27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01572"},{"key":"r28","volume-title":"Molecular Pathology in Clinical Practice","author":"Phillips KA","year":"2017","edition":"3"},{"key":"r29","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0703-1"},{"key":"r30","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-050124-082437"},{"key":"r31","unstructured":"National Cancer Institute. Germline mutation. NCI Dictionary of Genetics Terms. Accessed May 25, 2026. https:\/\/www.cancer.gov\/publications\/dictionaries\/genetics-dictionary\/def\/germline-mutation"},{"key":"r32","unstructured":"National Cancer Institute. Somatic mutation. NCI Dictionary of Genetics Terms. Accessed May 25, 2026. https:\/\/www.cancer.gov\/publications\/dictionaries\/genetics-dictionary\/def\/somatic-mutation"},{"key":"r33","doi-asserted-by":"publisher","DOI":"10.1007\/s12274-023-5567-4"},{"key":"r34","unstructured":"Centers for Disease Control and Prevention. Genetic testing. CDC. Reviewed May 15, 2024. Accessed May 25, 2026. https:\/\/www.cdc.gov\/genomics-and-health\/counseling-testing\/genetic-testing.html"},{"key":"r35","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00788-3"},{"key":"r36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16030583"},{"key":"r37","unstructured":"National Cancer Institute. Gene expression profile. NCI Dictionary of Cancer Terms. Accessed July 23, 2026. https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/gene-expression-profile"},{"key":"r38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.02.018"},{"key":"r39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.02.021"},{"issue":"4","key":"r40","first-page":"191","volume":"1","author":"T P A","year":"2009","journal-title":"J Clin Med Res"},{"issue":"4","key":"r41","first-page":"315","volume":"72","author":"Reizine NM","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"r42","unstructured":"National Cancer Institute. Definition of pharmacogenomics. NCI Dictionary of Cancer Terms. Accessed May 25, 2026. https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/pharmacogenomics"},{"issue":"7","key":"r43","first-page":"997","volume":"12","author":"Satam H","year":"2023","journal-title":"Biology (Basel)"},{"key":"r44","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2353893"},{"key":"r45","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2016.024"},{"key":"r46","unstructured":"National Cancer Institute. Biopsy. NCI Dictionary of Cancer Terms. Accessed July 23, 2026. https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/biopsy"},{"key":"r47","doi-asserted-by":"publisher","DOI":"10.4137\/CPath.S32784"},{"key":"r48","doi-asserted-by":"publisher","DOI":"10.37349\/etat.2023.00125"},{"key":"r49","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-25-0430"},{"key":"r50","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.51700"},{"key":"r51","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.8671"},{"key":"r52","unstructured":"U.S. Food & Drug Administration. List of cleared or approved companion diagnostic devices (in vitro and imaging tools). Updated December 2025. Accessed January 23, 2026. https:\/\/www.fda.gov\/medical-devices\/in-vitro-diagnostics\/list-cleared-or-approved-companion-diagnostic-devices-in-vitro-and-imaging-tools"},{"key":"r53","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2023.08.008"},{"key":"r54","doi-asserted-by":"publisher","DOI":"10.1007\/s43441-025-00799-7"},{"key":"r55","doi-asserted-by":"publisher","DOI":"10.1080\/10543406.2016.1226328"},{"key":"r56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmsacl.2023.02.008"},{"key":"r57","doi-asserted-by":"publisher","DOI":"10.1093\/jalm\/jfad091"},{"key":"r58","doi-asserted-by":"publisher","DOI":"10.1354\/vp.42-4-405"},{"key":"r59","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.07.014"}],"container-title":["Journal of Managed Care &amp; Specialty Pharmacy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T10:02:55Z","timestamp":1786183375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmcp.org\/doi\/10.18553\/jmcp.2026.32.9-b.s2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":59,"journal-issue":{"issue":"9-b Suppl","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.18553\/jmcp.2026.32.9-b.s2"],"URL":"https:\/\/doi.org\/10.18553\/jmcp.2026.32.9-b.s2","relation":{},"ISSN":["2376-0540","2376-1032"],"issn-type":[{"value":"2376-0540","type":"print"},{"value":"2376-1032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}